Emergent Biosolutions reported $2.69B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Akebia Therapeutics AKBA:US $ 502.67M 104.17M
ALKERMES ALKS:US 4.98B 1.04B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amarin AMRN:US 2.01B 284.24M
Ani Pharmaceuticals ANIP:US $ 418.86M 27.67M
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Chimerix CMRX:US $ 533.89M 156.11M
Coherus Biosciences CHRS:US $ 1.23B 181.38M
Emergent Biosolutions EBS:US $ 2.69B 686.55M
Exact Sciences EXAS:US $ 16.41B 4.91B
Exelixis EXEL:US $ 6.66B 950.22M
Flexion Therapeutics FLXN:US $ 306.78M 104.24M
Glaxosmithkline GSK:US 95.15B 3.61B
Heron Therapeutics HRTX:US $ 1.09B 490.97M
Immunogen IMGN:US $ 1.18B 139.17M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Ironwood Pharmaceuticals IRWD:US $ 2.14B 52.76M
JAZZ PHA JAZZ:US 7.99B 2.84B
Lexicon Pharmaceuticals LXRX:US $ 694.92M 32.18M
Lonza Group LONN:SW 48.84B 6.48B
Merk MRK:US $ 190131.55M 6786.63M
Moderna Inc MRNA:US $ 155.35B 61B
Myriad Genetics MYGN:US $ 2.52B 164.16M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Opko Health OPK:US $ 2.49B 227.89M
Pacira Pharmaceuticals PCRX:US $ 2.49B 182M
Pfizer PFE:US $ 241143.67M 21937.97M
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Sanofi SAN:FP 104.97B 6.43B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M
United Therapeutics UTHR:US $ 8.29B 249.36M
Vanda Pharmaceuticals VNDA:US $ 953.64M 241.55M
Xoma XOMA:US $ 279.95M 104.59M